nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Ticagrelor—coronary artery disease	0.0721	0.13	CbGbCtD
Scopolamine—ABCB1—Perindopril—coronary artery disease	0.0445	0.0806	CbGbCtD
Scopolamine—ABCB1—Clopidogrel—coronary artery disease	0.0445	0.0806	CbGbCtD
Scopolamine—ABCB1—Telmisartan—coronary artery disease	0.0389	0.0704	CbGbCtD
Scopolamine—ABCB1—Pitavastatin—coronary artery disease	0.0389	0.0704	CbGbCtD
Scopolamine—ABCB1—Enalapril—coronary artery disease	0.0369	0.0667	CbGbCtD
Scopolamine—ABCB1—Lisinopril—coronary artery disease	0.0369	0.0667	CbGbCtD
Scopolamine—ABCB1—Timolol—coronary artery disease	0.0314	0.0568	CbGbCtD
Scopolamine—ABCB1—Ezetimibe—coronary artery disease	0.0287	0.0519	CbGbCtD
Scopolamine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.028	0.0506	CbGbCtD
Scopolamine—ABCB1—Captopril—coronary artery disease	0.0276	0.05	CbGbCtD
Scopolamine—ABCB1—Simvastatin—coronary artery disease	0.0267	0.0483	CbGbCtD
Scopolamine—ABCB1—Lovastatin—coronary artery disease	0.0261	0.0472	CbGbCtD
Scopolamine—ABCB1—Pravastatin—coronary artery disease	0.0261	0.0472	CbGbCtD
Scopolamine—ABCB1—Atorvastatin—coronary artery disease	0.0238	0.043	CbGbCtD
Scopolamine—ABCB1—Losartan—coronary artery disease	0.0217	0.0393	CbGbCtD
Scopolamine—Hypotension—Furosemide—coronary artery disease	0.000241	0.000922	CcSEcCtD
Scopolamine—Vision blurred—Timolol—coronary artery disease	0.000241	0.000922	CcSEcCtD
Scopolamine—Hyperhidrosis—Losartan—coronary artery disease	0.00024	0.000921	CcSEcCtD
Scopolamine—Pain—Telmisartan—coronary artery disease	0.00024	0.00092	CcSEcCtD
Scopolamine—Constipation—Telmisartan—coronary artery disease	0.00024	0.00092	CcSEcCtD
Scopolamine—Agitation—Ramipril—coronary artery disease	0.00024	0.000919	CcSEcCtD
Scopolamine—Asthenia—Eplerenone—coronary artery disease	0.00024	0.000918	CcSEcCtD
Scopolamine—Mental disorder—Lisinopril—coronary artery disease	0.000238	0.000913	CcSEcCtD
Scopolamine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000237	0.000908	CcSEcCtD
Scopolamine—Erythema—Lisinopril—coronary artery disease	0.000237	0.000907	CcSEcCtD
Scopolamine—Pruritus—Eplerenone—coronary artery disease	0.000236	0.000905	CcSEcCtD
Scopolamine—Abdominal pain—Niacin—coronary artery disease	0.000236	0.000905	CcSEcCtD
Scopolamine—Body temperature increased—Niacin—coronary artery disease	0.000236	0.000905	CcSEcCtD
Scopolamine—Dizziness—Fenofibrate—coronary artery disease	0.000236	0.000903	CcSEcCtD
Scopolamine—Somnolence—Perindopril—coronary artery disease	0.000236	0.000903	CcSEcCtD
Scopolamine—Feeling abnormal—Trandolapril—coronary artery disease	0.000235	0.000902	CcSEcCtD
Scopolamine—Fatigue—Captopril—coronary artery disease	0.000235	0.000902	CcSEcCtD
Scopolamine—Vertigo—Ramipril—coronary artery disease	0.000235	0.000899	CcSEcCtD
Scopolamine—Feeling abnormal—Enalapril—coronary artery disease	0.000235	0.000898	CcSEcCtD
Scopolamine—Asthenia—Simvastatin—coronary artery disease	0.000234	0.000895	CcSEcCtD
Scopolamine—Constipation—Captopril—coronary artery disease	0.000233	0.000894	CcSEcCtD
Scopolamine—Abdominal pain—Pravastatin—coronary artery disease	0.000233	0.000891	CcSEcCtD
Scopolamine—Body temperature increased—Pravastatin—coronary artery disease	0.000233	0.000891	CcSEcCtD
Scopolamine—Hypotension—Losartan—coronary artery disease	0.000232	0.00089	CcSEcCtD
Scopolamine—Dizziness—Clopidogrel—coronary artery disease	0.000232	0.000887	CcSEcCtD
Scopolamine—Feeling abnormal—Telmisartan—coronary artery disease	0.000231	0.000886	CcSEcCtD
Scopolamine—Pruritus—Simvastatin—coronary artery disease	0.00023	0.000882	CcSEcCtD
Scopolamine—Dizziness—Lovastatin—coronary artery disease	0.00023	0.000882	CcSEcCtD
Scopolamine—Vertigo—Timolol—coronary artery disease	0.000229	0.000879	CcSEcCtD
Scopolamine—Somnolence—Furosemide—coronary artery disease	0.000229	0.000877	CcSEcCtD
Scopolamine—Fatigue—Perindopril—coronary artery disease	0.000228	0.000875	CcSEcCtD
Scopolamine—Pain—Perindopril—coronary artery disease	0.000227	0.000868	CcSEcCtD
Scopolamine—Constipation—Perindopril—coronary artery disease	0.000227	0.000868	CcSEcCtD
Scopolamine—Vomiting—Fenofibrate—coronary artery disease	0.000227	0.000868	CcSEcCtD
Scopolamine—Abdominal pain—Trandolapril—coronary artery disease	0.000226	0.000865	CcSEcCtD
Scopolamine—Body temperature increased—Trandolapril—coronary artery disease	0.000226	0.000865	CcSEcCtD
Scopolamine—Dizziness—Ezetimibe—coronary artery disease	0.000226	0.000865	CcSEcCtD
Scopolamine—Abdominal pain—Enalapril—coronary artery disease	0.000225	0.000862	CcSEcCtD
Scopolamine—Body temperature increased—Enalapril—coronary artery disease	0.000225	0.000862	CcSEcCtD
Scopolamine—Feeling abnormal—Captopril—coronary artery disease	0.000225	0.000862	CcSEcCtD
Scopolamine—Rash—Fenofibrate—coronary artery disease	0.000225	0.000861	CcSEcCtD
Scopolamine—Dermatitis—Fenofibrate—coronary artery disease	0.000224	0.00086	CcSEcCtD
Scopolamine—Headache—Fenofibrate—coronary artery disease	0.000223	0.000855	CcSEcCtD
Scopolamine—Vision blurred—Lisinopril—coronary artery disease	0.000223	0.000855	CcSEcCtD
Scopolamine—Vomiting—Clopidogrel—coronary artery disease	0.000223	0.000853	CcSEcCtD
Scopolamine—Fatigue—Furosemide—coronary artery disease	0.000222	0.000851	CcSEcCtD
Scopolamine—Tremor—Lisinopril—coronary artery disease	0.000222	0.00085	CcSEcCtD
Scopolamine—Abdominal pain—Telmisartan—coronary artery disease	0.000222	0.00085	CcSEcCtD
Scopolamine—Body temperature increased—Telmisartan—coronary artery disease	0.000222	0.00085	CcSEcCtD
Scopolamine—Vomiting—Lovastatin—coronary artery disease	0.000221	0.000848	CcSEcCtD
Scopolamine—Somnolence—Losartan—coronary artery disease	0.000221	0.000847	CcSEcCtD
Scopolamine—Dizziness—Eplerenone—coronary artery disease	0.000221	0.000846	CcSEcCtD
Scopolamine—Rash—Clopidogrel—coronary artery disease	0.000221	0.000846	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000221	0.000846	CcSEcCtD
Scopolamine—Dermatitis—Clopidogrel—coronary artery disease	0.000221	0.000845	CcSEcCtD
Scopolamine—Asthenia—Valsartan—coronary artery disease	0.000221	0.000845	CcSEcCtD
Scopolamine—Pain—Furosemide—coronary artery disease	0.00022	0.000844	CcSEcCtD
Scopolamine—Constipation—Furosemide—coronary artery disease	0.00022	0.000844	CcSEcCtD
Scopolamine—Asthenia—Olmesartan—coronary artery disease	0.000219	0.000841	CcSEcCtD
Scopolamine—Headache—Clopidogrel—coronary artery disease	0.000219	0.000841	CcSEcCtD
Scopolamine—Rash—Lovastatin—coronary artery disease	0.000219	0.000841	CcSEcCtD
Scopolamine—Dermatitis—Lovastatin—coronary artery disease	0.000219	0.00084	CcSEcCtD
Scopolamine—Feeling abnormal—Perindopril—coronary artery disease	0.000218	0.000837	CcSEcCtD
Scopolamine—Headache—Lovastatin—coronary artery disease	0.000218	0.000835	CcSEcCtD
Scopolamine—Pruritus—Valsartan—coronary artery disease	0.000217	0.000833	CcSEcCtD
Scopolamine—Dry mouth—Ramipril—coronary artery disease	0.000217	0.000833	CcSEcCtD
Scopolamine—Vomiting—Ezetimibe—coronary artery disease	0.000217	0.000831	CcSEcCtD
Scopolamine—Pruritus—Olmesartan—coronary artery disease	0.000216	0.000829	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000216	0.000827	CcSEcCtD
Scopolamine—Abdominal pain—Captopril—coronary artery disease	0.000216	0.000827	CcSEcCtD
Scopolamine—Body temperature increased—Captopril—coronary artery disease	0.000216	0.000827	CcSEcCtD
Scopolamine—Dizziness—Simvastatin—coronary artery disease	0.000215	0.000825	CcSEcCtD
Scopolamine—Rash—Ezetimibe—coronary artery disease	0.000215	0.000824	CcSEcCtD
Scopolamine—Dermatitis—Ezetimibe—coronary artery disease	0.000215	0.000824	CcSEcCtD
Scopolamine—Confusional state—Ramipril—coronary artery disease	0.000215	0.000823	CcSEcCtD
Scopolamine—Asthenia—Niacin—coronary artery disease	0.000214	0.000821	CcSEcCtD
Scopolamine—Fatigue—Losartan—coronary artery disease	0.000214	0.000821	CcSEcCtD
Scopolamine—Headache—Ezetimibe—coronary artery disease	0.000214	0.000819	CcSEcCtD
Scopolamine—Oedema—Ramipril—coronary artery disease	0.000213	0.000817	CcSEcCtD
Scopolamine—Vertigo—Lisinopril—coronary artery disease	0.000213	0.000815	CcSEcCtD
Scopolamine—Dry mouth—Timolol—coronary artery disease	0.000213	0.000814	CcSEcCtD
Scopolamine—Constipation—Losartan—coronary artery disease	0.000213	0.000814	CcSEcCtD
Scopolamine—Pain—Losartan—coronary artery disease	0.000213	0.000814	CcSEcCtD
Scopolamine—Vomiting—Eplerenone—coronary artery disease	0.000212	0.000814	CcSEcCtD
Scopolamine—Feeling abnormal—Furosemide—coronary artery disease	0.000212	0.000813	CcSEcCtD
Scopolamine—Nausea—Fenofibrate—coronary artery disease	0.000212	0.000811	CcSEcCtD
Scopolamine—Pruritus—Niacin—coronary artery disease	0.000211	0.00081	CcSEcCtD
Scopolamine—Asthenia—Pravastatin—coronary artery disease	0.000211	0.000809	CcSEcCtD
Scopolamine—Rash—Eplerenone—coronary artery disease	0.000211	0.000807	CcSEcCtD
Scopolamine—Dermatitis—Eplerenone—coronary artery disease	0.00021	0.000806	CcSEcCtD
Scopolamine—Confusional state—Timolol—coronary artery disease	0.00021	0.000805	CcSEcCtD
Scopolamine—Body temperature increased—Perindopril—coronary artery disease	0.00021	0.000803	CcSEcCtD
Scopolamine—Abdominal pain—Perindopril—coronary artery disease	0.00021	0.000803	CcSEcCtD
Scopolamine—Headache—Eplerenone—coronary artery disease	0.000209	0.000802	CcSEcCtD
Scopolamine—Nervous system disorder—Ramipril—coronary artery disease	0.000209	0.000801	CcSEcCtD
Scopolamine—Oedema—Timolol—coronary artery disease	0.000208	0.000798	CcSEcCtD
Scopolamine—Pruritus—Pravastatin—coronary artery disease	0.000208	0.000798	CcSEcCtD
Scopolamine—Nausea—Clopidogrel—coronary artery disease	0.000208	0.000797	CcSEcCtD
Scopolamine—Tachycardia—Ramipril—coronary artery disease	0.000208	0.000797	CcSEcCtD
Scopolamine—Skin disorder—Ramipril—coronary artery disease	0.000207	0.000793	CcSEcCtD
Scopolamine—Vomiting—Simvastatin—coronary artery disease	0.000207	0.000793	CcSEcCtD
Scopolamine—Nausea—Lovastatin—coronary artery disease	0.000207	0.000792	CcSEcCtD
Scopolamine—Hyperhidrosis—Ramipril—coronary artery disease	0.000206	0.000789	CcSEcCtD
Scopolamine—Rash—Simvastatin—coronary artery disease	0.000205	0.000786	CcSEcCtD
Scopolamine—Dermatitis—Simvastatin—coronary artery disease	0.000205	0.000785	CcSEcCtD
Scopolamine—Asthenia—Trandolapril—coronary artery disease	0.000205	0.000785	CcSEcCtD
Scopolamine—Feeling abnormal—Losartan—coronary artery disease	0.000205	0.000785	CcSEcCtD
Scopolamine—Nervous system disorder—Timolol—coronary artery disease	0.000204	0.000783	CcSEcCtD
Scopolamine—Asthenia—Enalapril—coronary artery disease	0.000204	0.000782	CcSEcCtD
Scopolamine—Headache—Simvastatin—coronary artery disease	0.000204	0.000781	CcSEcCtD
Scopolamine—Body temperature increased—Furosemide—coronary artery disease	0.000204	0.00078	CcSEcCtD
Scopolamine—Abdominal pain—Furosemide—coronary artery disease	0.000204	0.00078	CcSEcCtD
Scopolamine—Dizziness—Valsartan—coronary artery disease	0.000203	0.000779	CcSEcCtD
Scopolamine—Nausea—Ezetimibe—coronary artery disease	0.000203	0.000777	CcSEcCtD
Scopolamine—Skin disorder—Timolol—coronary artery disease	0.000202	0.000775	CcSEcCtD
Scopolamine—Dizziness—Olmesartan—coronary artery disease	0.000202	0.000775	CcSEcCtD
Scopolamine—Pruritus—Trandolapril—coronary artery disease	0.000202	0.000775	CcSEcCtD
Scopolamine—Hyperhidrosis—Timolol—coronary artery disease	0.000201	0.000772	CcSEcCtD
Scopolamine—Asthenia—Telmisartan—coronary artery disease	0.000201	0.000772	CcSEcCtD
Scopolamine—Pruritus—Enalapril—coronary artery disease	0.000201	0.000771	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.0002	0.000767	CcSEcCtD
Scopolamine—Hypotension—Ramipril—coronary artery disease	0.000199	0.000763	CcSEcCtD
Scopolamine—Pruritus—Telmisartan—coronary artery disease	0.000199	0.000761	CcSEcCtD
Scopolamine—Nausea—Eplerenone—coronary artery disease	0.000198	0.00076	CcSEcCtD
Scopolamine—Dizziness—Niacin—coronary artery disease	0.000198	0.000757	CcSEcCtD
Scopolamine—Dry mouth—Lisinopril—coronary artery disease	0.000197	0.000756	CcSEcCtD
Scopolamine—Body temperature increased—Losartan—coronary artery disease	0.000197	0.000753	CcSEcCtD
Scopolamine—Abdominal pain—Losartan—coronary artery disease	0.000197	0.000753	CcSEcCtD
Scopolamine—Asthenia—Captopril—coronary artery disease	0.000196	0.00075	CcSEcCtD
Scopolamine—Vomiting—Valsartan—coronary artery disease	0.000195	0.000749	CcSEcCtD
Scopolamine—Confusional state—Lisinopril—coronary artery disease	0.000195	0.000747	CcSEcCtD
Scopolamine—Hypotension—Timolol—coronary artery disease	0.000195	0.000746	CcSEcCtD
Scopolamine—Dizziness—Pravastatin—coronary artery disease	0.000195	0.000745	CcSEcCtD
Scopolamine—Vomiting—Olmesartan—coronary artery disease	0.000194	0.000745	CcSEcCtD
Scopolamine—Rash—Valsartan—coronary artery disease	0.000194	0.000742	CcSEcCtD
Scopolamine—Dermatitis—Valsartan—coronary artery disease	0.000194	0.000742	CcSEcCtD
Scopolamine—Nausea—Simvastatin—coronary artery disease	0.000193	0.000741	CcSEcCtD
Scopolamine—Oedema—Lisinopril—coronary artery disease	0.000193	0.000741	CcSEcCtD
Scopolamine—Pruritus—Captopril—coronary artery disease	0.000193	0.00074	CcSEcCtD
Scopolamine—Rash—Olmesartan—coronary artery disease	0.000193	0.000739	CcSEcCtD
Scopolamine—Dermatitis—Olmesartan—coronary artery disease	0.000193	0.000738	CcSEcCtD
Scopolamine—Headache—Valsartan—coronary artery disease	0.000193	0.000738	CcSEcCtD
Scopolamine—Headache—Olmesartan—coronary artery disease	0.000192	0.000734	CcSEcCtD
Scopolamine—Asthenia—Perindopril—coronary artery disease	0.00019	0.000728	CcSEcCtD
Scopolamine—Vomiting—Niacin—coronary artery disease	0.00019	0.000728	CcSEcCtD
Scopolamine—Somnolence—Ramipril—coronary artery disease	0.000189	0.000726	CcSEcCtD
Scopolamine—Dizziness—Trandolapril—coronary artery disease	0.000189	0.000724	CcSEcCtD
Scopolamine—Tachycardia—Lisinopril—coronary artery disease	0.000189	0.000723	CcSEcCtD
Scopolamine—Rash—Niacin—coronary artery disease	0.000188	0.000722	CcSEcCtD
Scopolamine—Dermatitis—Niacin—coronary artery disease	0.000188	0.000721	CcSEcCtD
Scopolamine—Dizziness—Enalapril—coronary artery disease	0.000188	0.000721	CcSEcCtD
Scopolamine—Skin disorder—Lisinopril—coronary artery disease	0.000188	0.000719	CcSEcCtD
Scopolamine—Pruritus—Perindopril—coronary artery disease	0.000188	0.000718	CcSEcCtD
Scopolamine—Headache—Niacin—coronary artery disease	0.000187	0.000717	CcSEcCtD
Scopolamine—Vomiting—Pravastatin—coronary artery disease	0.000187	0.000717	CcSEcCtD
Scopolamine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000187	0.000716	CcSEcCtD
Scopolamine—Dizziness—Telmisartan—coronary artery disease	0.000186	0.000711	CcSEcCtD
Scopolamine—Rash—Pravastatin—coronary artery disease	0.000186	0.000711	CcSEcCtD
Scopolamine—Dermatitis—Pravastatin—coronary artery disease	0.000185	0.00071	CcSEcCtD
Scopolamine—Somnolence—Timolol—coronary artery disease	0.000185	0.00071	CcSEcCtD
Scopolamine—Asthenia—Furosemide—coronary artery disease	0.000185	0.000708	CcSEcCtD
Scopolamine—Headache—Pravastatin—coronary artery disease	0.000184	0.000706	CcSEcCtD
Scopolamine—Fatigue—Ramipril—coronary artery disease	0.000184	0.000704	CcSEcCtD
Scopolamine—Nausea—Valsartan—coronary artery disease	0.000183	0.000699	CcSEcCtD
Scopolamine—Pruritus—Furosemide—coronary artery disease	0.000182	0.000698	CcSEcCtD
Scopolamine—Constipation—Ramipril—coronary artery disease	0.000182	0.000698	CcSEcCtD
Scopolamine—Nausea—Olmesartan—coronary artery disease	0.000182	0.000696	CcSEcCtD
Scopolamine—Vomiting—Trandolapril—coronary artery disease	0.000182	0.000696	CcSEcCtD
Scopolamine—Vomiting—Enalapril—coronary artery disease	0.000181	0.000693	CcSEcCtD
Scopolamine—Hypotension—Lisinopril—coronary artery disease	0.000181	0.000692	CcSEcCtD
Scopolamine—Dizziness—Captopril—coronary artery disease	0.000181	0.000692	CcSEcCtD
Scopolamine—Rash—Trandolapril—coronary artery disease	0.00018	0.00069	CcSEcCtD
Scopolamine—Dermatitis—Trandolapril—coronary artery disease	0.00018	0.00069	CcSEcCtD
Scopolamine—Fatigue—Timolol—coronary artery disease	0.00018	0.000688	CcSEcCtD
Scopolamine—Rash—Enalapril—coronary artery disease	0.000179	0.000687	CcSEcCtD
Scopolamine—Dermatitis—Enalapril—coronary artery disease	0.000179	0.000687	CcSEcCtD
Scopolamine—Headache—Trandolapril—coronary artery disease	0.000179	0.000686	CcSEcCtD
Scopolamine—Vomiting—Telmisartan—coronary artery disease	0.000178	0.000684	CcSEcCtD
Scopolamine—Asthenia—Losartan—coronary artery disease	0.000178	0.000683	CcSEcCtD
Scopolamine—Headache—Enalapril—coronary artery disease	0.000178	0.000683	CcSEcCtD
Scopolamine—Pain—Timolol—coronary artery disease	0.000178	0.000683	CcSEcCtD
Scopolamine—Nausea—Niacin—coronary artery disease	0.000178	0.00068	CcSEcCtD
Scopolamine—Rash—Telmisartan—coronary artery disease	0.000177	0.000678	CcSEcCtD
Scopolamine—Dermatitis—Telmisartan—coronary artery disease	0.000177	0.000677	CcSEcCtD
Scopolamine—Pruritus—Losartan—coronary artery disease	0.000176	0.000674	CcSEcCtD
Scopolamine—Headache—Telmisartan—coronary artery disease	0.000176	0.000674	CcSEcCtD
Scopolamine—Feeling abnormal—Ramipril—coronary artery disease	0.000176	0.000673	CcSEcCtD
Scopolamine—Dizziness—Perindopril—coronary artery disease	0.000175	0.000671	CcSEcCtD
Scopolamine—Nausea—Pravastatin—coronary artery disease	0.000175	0.00067	CcSEcCtD
Scopolamine—Vomiting—Captopril—coronary artery disease	0.000174	0.000665	CcSEcCtD
Scopolamine—Rash—Captopril—coronary artery disease	0.000172	0.000659	CcSEcCtD
Scopolamine—Dermatitis—Captopril—coronary artery disease	0.000172	0.000659	CcSEcCtD
Scopolamine—Somnolence—Lisinopril—coronary artery disease	0.000172	0.000658	CcSEcCtD
Scopolamine—Feeling abnormal—Timolol—coronary artery disease	0.000172	0.000658	CcSEcCtD
Scopolamine—Headache—Captopril—coronary artery disease	0.000171	0.000655	CcSEcCtD
Scopolamine—Dizziness—Furosemide—coronary artery disease	0.00017	0.000653	CcSEcCtD
Scopolamine—Nausea—Trandolapril—coronary artery disease	0.00017	0.00065	CcSEcCtD
Scopolamine—Nausea—Enalapril—coronary artery disease	0.000169	0.000648	CcSEcCtD
Scopolamine—Vomiting—Perindopril—coronary artery disease	0.000169	0.000646	CcSEcCtD
Scopolamine—Abdominal pain—Ramipril—coronary artery disease	0.000169	0.000646	CcSEcCtD
Scopolamine—Body temperature increased—Ramipril—coronary artery disease	0.000169	0.000646	CcSEcCtD
Scopolamine—Rash—Perindopril—coronary artery disease	0.000167	0.00064	CcSEcCtD
Scopolamine—Dermatitis—Perindopril—coronary artery disease	0.000167	0.00064	CcSEcCtD
Scopolamine—Nausea—Telmisartan—coronary artery disease	0.000167	0.000639	CcSEcCtD
Scopolamine—Fatigue—Lisinopril—coronary artery disease	0.000167	0.000638	CcSEcCtD
Scopolamine—Headache—Perindopril—coronary artery disease	0.000166	0.000636	CcSEcCtD
Scopolamine—Constipation—Lisinopril—coronary artery disease	0.000165	0.000633	CcSEcCtD
Scopolamine—Pain—Lisinopril—coronary artery disease	0.000165	0.000633	CcSEcCtD
Scopolamine—Abdominal pain—Timolol—coronary artery disease	0.000165	0.000631	CcSEcCtD
Scopolamine—Body temperature increased—Timolol—coronary artery disease	0.000165	0.000631	CcSEcCtD
Scopolamine—Dizziness—Losartan—coronary artery disease	0.000164	0.00063	CcSEcCtD
Scopolamine—Vomiting—Furosemide—coronary artery disease	0.000164	0.000628	CcSEcCtD
Scopolamine—Rash—Furosemide—coronary artery disease	0.000162	0.000622	CcSEcCtD
Scopolamine—Dermatitis—Furosemide—coronary artery disease	0.000162	0.000622	CcSEcCtD
Scopolamine—Nausea—Captopril—coronary artery disease	0.000162	0.000621	CcSEcCtD
Scopolamine—Headache—Furosemide—coronary artery disease	0.000161	0.000618	CcSEcCtD
Scopolamine—Feeling abnormal—Lisinopril—coronary artery disease	0.000159	0.00061	CcSEcCtD
Scopolamine—Vomiting—Losartan—coronary artery disease	0.000158	0.000606	CcSEcCtD
Scopolamine—Nausea—Perindopril—coronary artery disease	0.000157	0.000603	CcSEcCtD
Scopolamine—Rash—Losartan—coronary artery disease	0.000157	0.0006	CcSEcCtD
Scopolamine—Dermatitis—Losartan—coronary artery disease	0.000157	0.0006	CcSEcCtD
Scopolamine—Headache—Losartan—coronary artery disease	0.000156	0.000597	CcSEcCtD
Scopolamine—Nausea—Furosemide—coronary artery disease	0.000153	0.000586	CcSEcCtD
Scopolamine—Asthenia—Ramipril—coronary artery disease	0.000153	0.000586	CcSEcCtD
Scopolamine—Abdominal pain—Lisinopril—coronary artery disease	0.000153	0.000585	CcSEcCtD
Scopolamine—Body temperature increased—Lisinopril—coronary artery disease	0.000153	0.000585	CcSEcCtD
Scopolamine—Pruritus—Ramipril—coronary artery disease	0.000151	0.000578	CcSEcCtD
Scopolamine—Asthenia—Timolol—coronary artery disease	0.00015	0.000573	CcSEcCtD
Scopolamine—Nausea—Losartan—coronary artery disease	0.000148	0.000566	CcSEcCtD
Scopolamine—Pruritus—Timolol—coronary artery disease	0.000147	0.000565	CcSEcCtD
Scopolamine—Dizziness—Ramipril—coronary artery disease	0.000141	0.00054	CcSEcCtD
Scopolamine—Asthenia—Lisinopril—coronary artery disease	0.000139	0.000531	CcSEcCtD
Scopolamine—Dizziness—Timolol—coronary artery disease	0.000138	0.000528	CcSEcCtD
Scopolamine—Pruritus—Lisinopril—coronary artery disease	0.000137	0.000524	CcSEcCtD
Scopolamine—Vomiting—Ramipril—coronary artery disease	0.000136	0.000519	CcSEcCtD
Scopolamine—Rash—Ramipril—coronary artery disease	0.000134	0.000515	CcSEcCtD
Scopolamine—Dermatitis—Ramipril—coronary artery disease	0.000134	0.000514	CcSEcCtD
Scopolamine—Headache—Ramipril—coronary artery disease	0.000134	0.000512	CcSEcCtD
Scopolamine—Vomiting—Timolol—coronary artery disease	0.000132	0.000508	CcSEcCtD
Scopolamine—Rash—Timolol—coronary artery disease	0.000131	0.000503	CcSEcCtD
Scopolamine—Dermatitis—Timolol—coronary artery disease	0.000131	0.000503	CcSEcCtD
Scopolamine—Headache—Timolol—coronary artery disease	0.000131	0.0005	CcSEcCtD
Scopolamine—Dizziness—Lisinopril—coronary artery disease	0.000128	0.00049	CcSEcCtD
Scopolamine—Nausea—Ramipril—coronary artery disease	0.000127	0.000485	CcSEcCtD
Scopolamine—Nausea—Timolol—coronary artery disease	0.000124	0.000474	CcSEcCtD
Scopolamine—Vomiting—Lisinopril—coronary artery disease	0.000123	0.000471	CcSEcCtD
Scopolamine—Rash—Lisinopril—coronary artery disease	0.000122	0.000467	CcSEcCtD
Scopolamine—Dermatitis—Lisinopril—coronary artery disease	0.000122	0.000467	CcSEcCtD
Scopolamine—Headache—Lisinopril—coronary artery disease	0.000121	0.000464	CcSEcCtD
Scopolamine—Nausea—Lisinopril—coronary artery disease	0.000115	0.00044	CcSEcCtD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	8.74e-06	4.69e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOB—coronary artery disease	8.63e-06	4.63e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL2—coronary artery disease	8.61e-06	4.62e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOB—coronary artery disease	8.61e-06	4.62e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6R—coronary artery disease	8.59e-06	4.61e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	8.56e-06	4.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	8.53e-06	4.58e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOB—coronary artery disease	8.52e-06	4.57e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	8.52e-06	4.57e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GSK3B—coronary artery disease	8.5e-06	4.56e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EDN1—coronary artery disease	8.5e-06	4.56e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	8.49e-06	4.56e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EDN1—coronary artery disease	8.47e-06	4.55e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1—coronary artery disease	8.47e-06	4.54e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	8.45e-06	4.54e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—POMC—coronary artery disease	8.43e-06	4.52e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CREB1—coronary artery disease	8.43e-06	4.52e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL5—coronary artery disease	8.43e-06	4.52e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—MAPK1—coronary artery disease	8.43e-06	4.52e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	8.41e-06	4.51e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AGT—coronary artery disease	8.41e-06	4.51e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL5—coronary artery disease	8.4e-06	4.51e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EDN1—coronary artery disease	8.39e-06	4.5e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL5—coronary artery disease	8.32e-06	4.47e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CSF2—coronary artery disease	8.3e-06	4.46e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGF1—coronary artery disease	8.3e-06	4.46e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CSF2—coronary artery disease	8.28e-06	4.44e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGF1—coronary artery disease	8.28e-06	4.44e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL2—coronary artery disease	8.25e-06	4.43e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LPL—coronary artery disease	8.24e-06	4.42e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—coronary artery disease	8.24e-06	4.42e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6R—coronary artery disease	8.22e-06	4.41e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LPL—coronary artery disease	8.22e-06	4.41e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PLCB1—coronary artery disease	8.2e-06	4.4e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGF1—coronary artery disease	8.2e-06	4.4e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CSF2—coronary artery disease	8.2e-06	4.4e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	8.17e-06	4.38e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	8.17e-06	4.38e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	8.14e-06	4.37e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	8.14e-06	4.37e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOA1—coronary artery disease	8.14e-06	4.37e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LPL—coronary artery disease	8.14e-06	4.37e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1—coronary artery disease	8.11e-06	4.35e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—MAPK1—coronary artery disease	8.07e-06	4.33e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	8.07e-06	4.33e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	8.07e-06	4.33e-05	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PIK3CA—coronary artery disease	8.05e-06	4.32e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—coronary artery disease	8.04e-06	4.32e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	7.96e-06	4.27e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ABCA1—coronary artery disease	7.95e-06	4.26e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	7.94e-06	4.26e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	7.86e-06	4.22e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGF2—coronary artery disease	7.78e-06	4.18e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	7.77e-06	4.17e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	7.75e-06	4.16e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	7.73e-06	4.15e-05	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PIK3CA—coronary artery disease	7.71e-06	4.14e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	7.71e-06	4.14e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—coronary artery disease	7.7e-06	4.13e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GGT1—coronary artery disease	7.7e-06	4.13e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GOT1—coronary artery disease	7.7e-06	4.13e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOS3—coronary artery disease	7.68e-06	4.12e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	7.67e-06	4.12e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	7.64e-06	4.1e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	7.6e-06	4.08e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	7.57e-06	4.06e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	7.5e-06	4.02e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—JAK2—coronary artery disease	7.46e-06	4e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGF2—coronary artery disease	7.46e-06	4e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	7.43e-06	3.99e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—C3—coronary artery disease	7.42e-06	3.98e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	7.41e-06	3.98e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—C3—coronary artery disease	7.4e-06	3.97e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOS3—coronary artery disease	7.35e-06	3.95e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	7.34e-06	3.94e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—C3—coronary artery disease	7.33e-06	3.93e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PIK3CA—coronary artery disease	7.31e-06	3.92e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—coronary artery disease	7.18e-06	3.85e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—JAK2—coronary artery disease	7.15e-06	3.84e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	7.08e-06	3.8e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—POMC—coronary artery disease	7.08e-06	3.8e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	7.06e-06	3.79e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGT—coronary artery disease	7.05e-06	3.78e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGT—coronary artery disease	7.03e-06	3.77e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PIK3CA—coronary artery disease	7e-06	3.76e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	6.99e-06	3.75e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGT—coronary artery disease	6.96e-06	3.74e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTP1—coronary artery disease	6.91e-06	3.71e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—coronary artery disease	6.91e-06	3.71e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LEP—coronary artery disease	6.91e-06	3.71e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—coronary artery disease	6.89e-06	3.7e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LEP—coronary artery disease	6.89e-06	3.7e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	6.85e-06	3.68e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOA1—coronary artery disease	6.83e-06	3.67e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LEP—coronary artery disease	6.82e-06	3.66e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—coronary artery disease	6.82e-06	3.66e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—coronary artery disease	6.82e-06	3.66e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL8—coronary artery disease	6.81e-06	3.66e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOA1—coronary artery disease	6.81e-06	3.65e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KDR—coronary artery disease	6.77e-06	3.63e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KDR—coronary artery disease	6.75e-06	3.62e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	6.74e-06	3.62e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CAT—coronary artery disease	6.73e-06	3.61e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	6.73e-06	3.61e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	6.7e-06	3.6e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KDR—coronary artery disease	6.68e-06	3.59e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	6.64e-06	3.56e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	6.6e-06	3.54e-05	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—coronary artery disease	6.58e-06	3.53e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	6.58e-06	3.53e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOB—coronary artery disease	6.53e-06	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	6.52e-06	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CASP3—coronary artery disease	6.52e-06	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FN1—coronary artery disease	6.52e-06	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—F2—coronary artery disease	6.52e-06	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	6.51e-06	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FN1—coronary artery disease	6.5e-06	3.49e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—F2—coronary artery disease	6.5e-06	3.49e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	6.49e-06	3.48e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—coronary artery disease	6.48e-06	3.48e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	6.47e-06	3.47e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—coronary artery disease	6.45e-06	3.46e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	6.44e-06	3.46e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FN1—coronary artery disease	6.43e-06	3.45e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—F2—coronary artery disease	6.43e-06	3.45e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	6.42e-06	3.44e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	6.41e-06	3.44e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	6.36e-06	3.41e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTM1—coronary artery disease	6.35e-06	3.41e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCND1—coronary artery disease	6.34e-06	3.41e-05	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	6.3e-06	3.38e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CASP3—coronary artery disease	6.24e-06	3.35e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KIT—coronary artery disease	6.24e-06	3.35e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LPL—coronary artery disease	6.24e-06	3.35e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KIT—coronary artery disease	6.22e-06	3.34e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—coronary artery disease	6.2e-06	3.33e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NOS3—coronary artery disease	6.17e-06	3.31e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—coronary artery disease	6.16e-06	3.31e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KIT—coronary artery disease	6.16e-06	3.3e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX1—coronary artery disease	6.08e-06	3.27e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCND1—coronary artery disease	6.08e-06	3.26e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	5.98e-06	3.21e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—coronary artery disease	5.97e-06	3.21e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	5.97e-06	3.2e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—POMC—coronary artery disease	5.94e-06	3.19e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	5.94e-06	3.19e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CD36—coronary artery disease	5.92e-06	3.18e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—POMC—coronary artery disease	5.92e-06	3.18e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	5.92e-06	3.18e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	5.91e-06	3.17e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—coronary artery disease	5.9e-06	3.17e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—POMC—coronary artery disease	5.86e-06	3.14e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	5.86e-06	3.14e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPP2CA—coronary artery disease	5.85e-06	3.14e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	5.81e-06	3.12e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	5.79e-06	3.11e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	5.79e-06	3.11e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	5.77e-06	3.1e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	5.73e-06	3.08e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	5.72e-06	3.07e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	5.72e-06	3.07e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	5.71e-06	3.06e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	5.69e-06	3.05e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	5.68e-06	3.05e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	5.66e-06	3.04e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—coronary artery disease	5.64e-06	3.03e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	5.64e-06	3.03e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—coronary artery disease	5.61e-06	3.01e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	5.61e-06	3.01e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—coronary artery disease	5.53e-06	2.97e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	5.43e-06	2.91e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	5.42e-06	2.91e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	5.41e-06	2.91e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	5.41e-06	2.9e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	5.36e-06	2.88e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	5.35e-06	2.87e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AGT—coronary artery disease	5.33e-06	2.86e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	5.3e-06	2.84e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	5.25e-06	2.82e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	5.23e-06	2.81e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—coronary artery disease	5.23e-06	2.81e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	5.18e-06	2.78e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	5.18e-06	2.78e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOA1—coronary artery disease	5.17e-06	2.77e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	5.16e-06	2.77e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	5.11e-06	2.74e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	5.08e-06	2.72e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	5.03e-06	2.7e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	5.02e-06	2.69e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	4.98e-06	2.67e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	4.97e-06	2.67e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	4.93e-06	2.65e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	4.92e-06	2.64e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	4.87e-06	2.61e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	4.86e-06	2.61e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	4.77e-06	2.56e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	4.59e-06	2.46e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	4.58e-06	2.46e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—coronary artery disease	4.55e-06	2.44e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	4.53e-06	2.43e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—POMC—coronary artery disease	4.49e-06	2.41e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	4.44e-06	2.38e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	4.42e-06	2.37e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	4.4e-06	2.36e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	4.38e-06	2.35e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	4.38e-06	2.35e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	4.37e-06	2.34e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	4.35e-06	2.34e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	4.34e-06	2.33e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	4.32e-06	2.32e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	4.31e-06	2.31e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	4.28e-06	2.3e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	4.26e-06	2.29e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	4.22e-06	2.27e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	4.15e-06	2.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	4.14e-06	2.22e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	4.14e-06	2.22e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	4.1e-06	2.2e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—coronary artery disease	4.09e-06	2.2e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	4.03e-06	2.16e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	4.02e-06	2.16e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	3.98e-06	2.13e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NOS3—coronary artery disease	3.92e-06	2.1e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—coronary artery disease	3.83e-06	2.05e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	3.73e-06	2e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	3.72e-06	2e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	3.68e-06	1.98e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—coronary artery disease	3.66e-06	1.97e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—coronary artery disease	3.58e-06	1.92e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—coronary artery disease	3.53e-06	1.89e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CA—coronary artery disease	3.47e-06	1.86e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	3.42e-06	1.84e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	3.41e-06	1.83e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—coronary artery disease	3.38e-06	1.81e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	3.38e-06	1.81e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	3.36e-06	1.8e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	3.35e-06	1.8e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	3.31e-06	1.78e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.91e-06	1.56e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	2.9e-06	1.56e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	2.88e-06	1.54e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—coronary artery disease	2.84e-06	1.52e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—coronary artery disease	2.58e-06	1.38e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—coronary artery disease	2.57e-06	1.38e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—coronary artery disease	2.55e-06	1.37e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.38e-06	1.28e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	2.37e-06	1.27e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.35e-06	1.26e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.2e-06	1.18e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—coronary artery disease	1.8e-06	9.66e-06	CbGpPWpGaD
